Comparison

GHRP-2 vs Sermorelin

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

GHRP-2

Also: Growth Hormone Releasing Peptide 2, Pralmorelin

Clinical Trials

A synthetic hexapeptide that potently stimulates GH release. More potent than GHRP-6 with less appetite stimulation, but still elevates cortisol and prolactin.

Growth HormoneHuman Trials
Sermorelin

Also: Geref, GRF 1-29

Preclinical

A truncated analog of natural GHRH containing the first 29 amino acids. Previously FDA-approved for pediatric GH deficiency, now used off-label for adult hormone optimization.

Growth HormoneAnimal Studies

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
  • GHRP-2 has stronger research evidence (Human Trials) compared to Sermorelin (Animal Studies).

Detailed Comparison

AttributeGHRP-2Sermorelin
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionGHRP-2 acts on ghrelin receptors to stimulate GH release from the pituitary. It has the strongest GH-releasing effect among GHRPs but also causes more cortisol and prolactin release than ipamorelin. Less appetite stimulation than GHRP-6.Sermorelin is bioidentical to the active portion of endogenous GHRH. It stimulates the pituitary's natural production and release of growth hormone, maintaining normal feedback mechanisms and pulsatile GH release patterns.
Common Dosing
100-300 mcg 2-3x daily
2-3x daily
200-500 mcg before bed
Once daily, typically before bed
AdministrationSubcutaneous injectionSubcutaneous injection at bedtime
Typical Duration8-12 weeks3-6 months typical
Best Time to TakeBefore bed or morning (fasted)Before bed (fasted)
Possible Side Effects
May vary by individual
  • Increased appetite (less than GHRP-6)
  • Water retention
  • Fatigue
  • Headache
  • Nausea
  • +3 more
  • Facial flushing (most common)
  • Injection site reactions
  • Headache
  • Nausea
  • Dizziness
  • +4 more
Research SummaryStudies show it produces the highest GH release among common GHRPs. Research demonstrates reliable diagnostic use for GH deficiency testing. Animal studies show improved muscle mass and recovery.Extensive clinical research from FDA approval process. Studies demonstrate restoration of youthful GH levels, improved sleep quality, increased lean body mass, and enhanced recovery. Generally preserves natural GH axis better than exogenous GH.

Frequently Asked Questions: GHRP-2 vs Sermorelin

What is the difference between GHRP-2 and Sermorelin?

GHRP-2 is a growth hormone peptide that a synthetic hexapeptide that potently stimulates gh release. more potent than ghrp-6 with less appetite stimulation, but still elevates cortisol and prolactin. Sermorelin is a growth hormone peptide that a truncated analog of natural ghrh containing the first 29 amino acids. previously fda-approved for pediatric gh deficiency, now used off-label for adult hormone optimization. The main differences lie in their mechanisms of action and clinical applications.

Which is better, GHRP-2 or Sermorelin?

Neither is universally "better" - the choice depends on your specific goals. GHRP-2 is typically used for growth hormone purposes, while Sermorelin is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can GHRP-2 and Sermorelin be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using GHRP-2 and Sermorelin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of GHRP-2 and Sermorelin is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.